SUPPORT THE KAYO LIFE SCIENCES FORUM
Be a support to the small percentage of women who are in your industry.
COVID-19 has created a defining moment for the life sciences sector. Investors, executives and advisors will come together to explore life science investing, deal trends, emerging areas of disruption, regulatory developments, and an outlook for 2022 and beyond.
Please join the waitlist below to be the first to know when registration opens for the Kayo Life Sciences Forum.
be first to know
who should attend
INVESTORS
Private equity, alternative debt, venture capital, growth equity, placement agents, investment banks, and lenders.
EXECUTIVES
Senior and Emerging Leaders at Life Sciences, Biotech and Pharma Companies.
ADVISORS
Finance, legal and consulting advisors to life sciences investors.
AGENDA
Our 2021 program includes over 15 speakers and 60 minutes of networking.
12:00PM – 4:00PM ET: Virtual Programming
Keynote, Panels, Speed Networking
THE VENUE
Hopin is a virtual event platform with multiple interactive areas that are optimized for connecting and engaging. Attendees can move in and out of rooms just like an in-person event for both content and connections.
agenda overview
SPEAKERS
Hear from 15 thought leaders from across the technology and private equity landscape.
SPEED NETWORKING
1:1 speed networking where you can easily make multiple connections authentically and easily from your virtual workspace.
SMALL GROUPS
Small group sessions allow for intimate discussions between groups of 10-20 with moderators to keep discussions flowing.
speakers
UCIANE SCARLETT
Oxford Sciences Innovation
JO VINEY
Pandion Therapeutics
LIZ SCHWARZBACH
BigHat Biosciences
KYPARISSIA (KYP) SIRINAKIS
Epidarex
sponsors
PLATINUM
“THE TRAILBLAZER”
GOLD
SILVER
trailblaze together
UPCOMING EVENTS
Where will you make your next connection?
BECOME A SPONSOR
The women in your industry are leading the way. Be the support they need.
APPLY TO SPEAK
Share your insights and how-tos with your peers.
Let's join forces. Let's trailblaze together.